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The carbohydrate chains of the pathological human immunoglobulins M from two patients with 
Waldenstrom’s macroglobulinemia were released by hydrazinolysis. The N-acetyllactosamine-type glycans 
were obtained by affinity chromatography on concanavalin A and fractionated by high-voltage paper 
electrophoresis. The primary structure of the major compounds was elucidated on the basis of 
carbohydrate analysis, methylation analysis, including mass-spectrometry, and 500 MHz ‘H-NMR 
spectroscopy. For both patients, this appeared to be a monosialyl monofucosyl biantennary structure; the 
compounds differed by the presence of an intersecting N-acetylglucosamine residue. 
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1. INTRODUCTION 
Immunoglobulins M (IgMs) are glycoproteins 
that have a relatively high (7-15%) carbohydrate 
content and show a large chemical heterogeneity 
of the oligosaccharides conjugated to the heavy 
chains. In [l] an illustration of such a hetero- 
geneity has been given: oligosaccharides derived 
from normal as well as from pathological human 
IgMs could be fractionated by affinity-chromato- 
graphy into N-acetyllactosamine-type and oligo- 
mannoside-type carbohydrate chains. 
The structure of the oligosaccharides of im- 
munoglobulins .M has been investigated for more 
than a decade. Meanwhile, their oligomannoside- 
type structures are rather well established [2-51; 
however, as to the N-acetyllactosamine type, so far 
only a structure of the biantennary type was found, 
either fucosylated [6] or non-fucosylated; the latter 
forms part of, for example, the J-chain of a patho- 
logical human IgM [7]. In addition, for mouse 
plasmocytoma IgM a glycan of the triantennary 
type was described [S]. 
Here we report the primary structure of each of 
the major glycans of the N-acetyllactosamine type, 
derived from two pathological-human IgMs. The 
structural studies involved hydrazinolysis, followed 
by determination of carbohydrate composition, 
methylation analysis including mass-spectrometry, 
and 500-MHz ‘H-NMR spectroscopy. 
Abbreviations: Fuc, L-fucose; Gal, D-galactose; Man, 
D-mannose; GlcNAc, N-acetyl-D-glucosamine; NeuAc, 
N-acetylneuraminic acid; IgM, immunoglobulin M; 
Con A, concanavalin A 
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2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
Pathological human IgMs were prepared from 
plasmaphaereses of patients (ZAJ) and (GRA) 
with Wald~~str~m’s macro~lobulinemia s in 191; 
i.e., IgM(ZAJ) bycryoprecipitationandIgM(GRA) 
by euglobulin precipitation. NaB3H4-reduced oligo- 
saccharides obtained from the native molecules by 
hydr~inolysis and subsequent reduction were 
separated by affinity chromatography ore a Con A 
column. The glycans were characterized previously 
[l], with respect to their binding capacity with 
Con A [la], as oligomannaside-type and N-acetyl- 
lactosamine-type chains. The major fractions of 
the latter type of IgM(ZAJ) (41%) and of 
IgM(GRA) (~8~~) were further subfractionated by 
high-voitage electrophoresis on Whatman 3MM 
paper in [buffer] pyrimidine-acetic acid-water 
(18 : 6 : 2320, by vol., pH 5.4) at 75 V/cm for 3 h at 
4°C. Radioactive strips were cut and eluted with 
water. Standards used were asialyl (N), monosialyl 
(MS) and disialyl (IX) biantennary structures 
]11,12] obtained from human serum transferrin by 
hydrazinolysis. 
Reduced oligosaccharides obtained from the two 
pathological IgMs (ZAJ and GRA) were frac- 
tionated by affinity chromatography on a Con A 
column [lo] into biantennary N-acetyllactosamine- 
type structures exhibiting a weak affinity for 
Con A and more complex structures having no 
affinity for Con A. Each of these fractions was 
submitted to high-voltage paper electrophoresis, 
affording 3 subfractions (fig.1). The latter co- 
migrated with the reference compounds, namely, 
t 
Molar ratios of monosaccharides were deter- 
mined after methanolysis and trifluoroacetylation 
by gas-liquid chromatography f 131. Exhaustive 
methylati~n of reduced oligosaccharides was car- 
ried out as in [14]. The mdhylglycosides obtained 
by methanalysis of permethylated oligosaccharides 
were peracetylated and identified by gas-liquid 
chromatography coupled to mass-spectrometry, as 
in fl5] 
For NMR analysis, the reduced oligosaccharide 
fractions were repeatedly treated with DzO at 
pD - 7 and room temperature. After each ex- 
change treatment, the materials were lyophilized. 
Finally, each sample was dissolved in 400~1 DzO 
(99,% atom% D, Aldrich). 500-MHz ‘H-NMR 
spectroscopy was performed on a Bruker WM-500 
spectrometer (SON hf-MNR facility, Department 
of Biophysical Chemistry, Nijmegen University, 
The Netherlands), operating under control of an 
Aspect-2000 computer. Experimental details have 
been described 1161. The probe temperature was 
kept at 27 (40. l)OC. Chemical shifts are expressed 
in ppm downfield from internal sodium 4,4- 
dimethyl-4-silapentane-1-sulfanate (DSS), but were 
actually measured by reference to internal acetone 
(S 2.225 in I320 at 27*C), with an accuracy of 
0.002 ppm. 
0 IO 20 30 
DISTANCE FROM ORIGIN (cm) 
F’ig. f. ~adioelectro~~erogram of the NaB3H4-reduced 
oiigo~ccb~ides derived from IgM(ZAJ) and from 
I~M(e~A) by hydraz~noIysis (for details, see section 
3.1). N, neutral; MS, monosialyl; DS, disialyl oligosac- 
charide fractions. The arrows indicate the position of the 
fallowing standards: asiaiylated (SO), monosialylated 
(Sx) and disialytated (Sz) biantennary glycans from 
human serum transferrin. 
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Table I Table 2 
Molar carbohydrate composition of fractions (MS) ob- 
tained by high-voltage electrophoresis from IgM(ZAJ) 
and IgM(GRA) 
Molar ratios of monosaccharide methyl ethers present in 
the methanolysates of the permethylated major fractions 
MS isolated from IgM(ZAJ) and IgM(GRA) 
Monosaccharide WWAJ) IgM(GRA) 
Fuc 1.20 0.74 
Gal 1.90 2.00 
Man 3.00 3.00 
GlcNAc 2.80 4.00 
GlcNAcitol 0.73 0.53 
Neu AC 0.79 0.64 
The molar ratios were calculated on the basis of 3 
mannose residues 
the neutral (N), rn~nosi~yl (MS) and disialyl (DS) 
oligosaccharides. For IgM(ZAJ), proportions of 
these sub-fractions were found to be: N, 23%; MS, 
61%; DS, 16%, and for IgM(GRA) they were: N, 
15%; MS, 73% DS, 12%. 
These fractions appeared homogeneous by thin- 
layer chromatography (TLC) on silica gel for 
IgM(ZAJ), but heterogeneous for IgM(GRA), 
6 = 2 4 
NeuAc alZ-S)Gali3(1-1)GlcNAc~(l-ZlManrr(l--31 
\;3. 
Monosacharide methyl 
ethers 
Fraction Fraction 
MS from MS from 
IgM(ZAJ) IgM(GRA) 
(2,3,4)-Me3-Fuc 0.5 
(2,3,4,6)-M&-Gal 0.7 
(2,3,4)-Mes-Gal 1.0 
(3,4,6)-Me3-Man 1.5 
(3,6)-Mez-Man - 
(3,4)-Mez-Man - 
(2,4)-Mez-Man 0.8 
(2)-Mel-Man - 
(1,3,5)- 
(1,3,5)-Me3-GlcN(Me)AcitoI 0.5 
(3,4,6)-Mew-GlcN(Me)Ac - 
(3,6)-Met-GIc(Me)Ac 2.2 
(4,7,8,9)-Mea-Neu(Me)Ac 0.7 
0.4 
0.7 
1.0 
2.2 
0.0” 
0.1 
0.1 
0.9 
0.4 
0.9 
2.6 
0.5 
a Traces, not determined 
The molar ratios were calculated on the basis of 1 resi- 
due of (2,3,4)-Mex-Gal (=2,3,4-tri-O-methyl galactose) 
GalP(l--L)GlrNAcp(t-Z)Manor(l-6) / Fucaif-6) 
/ 
6 5’ L 
NAc CHO protons 
= = = 
I I 
55 
-6(ppm) 
50 45 40 35 30 25 20 15 10 
Fig.2. SOO-MHz ‘H-NMR spectrum (D20; pD 7; 27’C) of the monosialyl reduced-oligosaccharide fraction obtained 
from IgMfGRA). The numbers in the spectrum refer to the corresponding residues in the structure. The appearance 
of the asterisk-marked oublet-of-doublets at S 3.27, clearly apart from the bulk of skeleton-proton signais, has been 
proposed 1171 to be correlated with the presence of GlcNAc-9 in the structure. So far, this signal could not be assigned 
unambiguously. 
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3.2. Primary structure determination Table 3 
The primary structure of the major fractions MS 
obtained from IgMs(ZAJ) and (GRA) was estab- 
lished on the basis of sugar composition (table I), 
the results of methylation analysis (table 2) and 
500-MHz ‘H-NMR spectroscopy. 
‘H chemical shifts of structural reporter groups of con- 
stituent monosa~ha~des for the monosialylated ohgo- 
sac~haride-alditols obtained from IgM of patients ZAJ 
and GRA 
500-MHz ‘H-NMR spectra were recorded of 
neutral D&solutions of the fractions MS ob- 
tained from IgM(ZAJ) and IgM(GRA). The spec- 
trum of the latter is depicted in fig.2. The chemical 
shifts of the structural-reporter groups for both 
fractions have been compiled in table 3. 
Reporter 
group 
Residue” Chemical shiftbSc in 
IgM(ZAJ) IgM(~RA~ 
The ‘H-NMR data for the IgM(ZAJ) preparation 
point to the presence of a monosialyl biantennary 
oligosaccharide-alditol of the ~-acetyllactosamine 
type. The reasoning is as follows. The reduced 
GlcNAc-1 lacks an anomeric proton signal, but 
instead it has its H-2 signal as structural-reporter 
group at S 4,220, among the Man H-2 signals. The 
N-acetyl singIet at 6 2.057 is ascribed to this 
GlcNAc-of residue (cf. [I%--20]). H-f and the NAc 
methyl protons of GlcNAc-2, @(l -+ 4) linked to 
GlcNAc-1-ol, were found to resonate at 6 4.714 
and S 2.088, respectively (see table 3). The devia- 
tions of these values from those reported pre- 
viously, namely, &H-l 4.637 and GNAc 2.076 
[l&19], are attributed to the presence of Fuc in 
~(1 -+ Q-linkage to GlcNAc-l-01. The 4,6-disub- 
stitution of GlcNAc-01 is evident from the results 
of methylation analysis (table 2). Fuc being linked 
to C-6 is further substantiated by the magnitude of 
the downfield shifts of H-l and NAc of GlcNAc-2 
as compared to afucosyl structures (for H-l, AS - 
0.08 ppm; for NAc, A& = 0,012 ppm, cf. (161). The 
coupling constant J1.2 for Fuc, being 3.8 Hz, indi- 
cates the a-anomeric configuration of this linkage. 
The set of chemical shift values for the Fuc re- 
porter groups, i.e., H-l, H-5 and CH3, are con- 
siderably altered due to the presence of GlcNAc-01 
instead of GlcNAc @(l + N)-Asn (cf. table 3 with 
[16]). The remaining set of chemical shift values 
listed for IgM(ZAJ) in table 3 shows a very close 
resemblance with those reported for a correspon- 
ding glycopeptide and reducing oligosaccharide 
(compounds 31 and 27 fl6]). This defines the type 
of branching to the biantennary, and the NeuAc 
residue to be ~y(2 + @-linked to Gal-6 rather than 
to Gal-6’ [16]. 
H-l GicNAc-2 
Man-3 
Man-4 
Man-4’ 
GlcNAc-5 
GlcNAc-5’ 
Gal-6 
Gal-6” 
GlcNAc-9 
Fuc 
H-2 GlcNAc- l-01 
Man-3 
Man-4 
Man-4” 
W-3ilX 
H&q 
H-S 
cf43 
NeuAc 
NeuAc 
Fuc 
Fuc 
NAc GlcNAc- l-01 
GlcNAc-2 
GlcNAc-5 
GlcNAc-5’ 
GlcNAc-9 
NeuAc 
4.q4 4.716 
4.760 4.705 
5.136 5.077 
4.924 5.005 
4.605 4.617 
4.581 4.576 
4.445 4.444 
4.470 4.476 
- 4.467 
4.896 4.904 
4.220 4.214 
4.258 4.187 
4.197 4.260 
4.110 4.142 
1.720 1.722 
2.668 2.673 
4.071 4.068 
1.224 1 .224d 
2.057 2.055 
2.088 2.092 
2.071 2.081 
2.048 2.042 
- 2.066 
2.031 2.03f 
On the basis of similar features in the spectra ob- 
a For numbering of monosaccharide residues and com- 
plete structures, see fig.2,3 
b Chemical shifts are given for neutral solutions at 27”C, 
in ppm downfield from internal DSS In DzO 
’ Compounds are represented by schematic structures 
(cf. Il6J); (~1 GIcNAc, (+---I Man, (l-1 Gal, 
(tzt----) FUC, (CP--$ NeuAc 
dA doubling of this doublet (S 1.224 and 1.2203 was 
observed upon resolution-enhancement of the spec- 
trum. So far this feature could not be explained 
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A 
B 
c 5 ! 
NeuAca(2+6)Gal~(l+4)Gl~NAc~(l+2)Mana(l+3) 
\ 3 2 1 
,&(1+4)Gl;NAcP(l+4)Gl;NAc-ol 
I 
Fuca(1+6)' 
Gal~(l+4)GlcNAc~(l+2)Man~(l+6)' 
G' 5' = = A' 
6 5 = = f 
2 = 
G1cNAc~(1+4)-ManP(1+4)G1cNAc~( 1+4)Gl cNAc-ol 
i? 
/ 
Fuccl(l-6) / 
Gal~(1+4)GlcNAc~(1-+2)Flancr(1+6j 
5' 5' = 4' 
Fig.3. Primary structures of the major N-acetyllactosamine-typeglycans isolated from IgM(ZAJ) (A) and IgM(GRA) (B). 
tained from IgM(GRA) (see fig.2) and IgM(ZAJ), 
the presence of the ( --* 4)GlcNAc p(1 --) 4) [Fuc 
cu(1 --, 6)]-GlcNAc-01 moiety is concluded. The 
typical set of Man H-l and H-2 chemical shifts for 
IgM(GRA) (see table 3) point to the intersected 
biantennary type of branching, as was observed in 
[16,21-231. The typical parameters of the inter- 
secting GlcNAc-9 residue, namely, its H-l signal at 
S 4.467 (Jr,2 8.0 Hz), and its NAc singlet at 6 2.066, 
are not influenced by the reduced nature of 
GlcNAc-I. As with IgM(ZAJ), the sialic acid resi- 
due could readily be located by NMR in (~(2 + 6)- 
linkage to Gal-6 in the (l--)3)-linked branch, 
because of the specific influences on the chemical 
shifts of H-l of Man-4 and Gal-6, and of NAc of 
GlcNAc-5, as compared to the corresponding 
asialylated structure [ 16,211. 
The structures of the glycans present in fractions 
MS from IgM(ZAJ) and IgM(GRA), as deduced 
by ‘H-NMR spectroscopy in combination with 
sugar and methylation analyses, are presented in 
fig.3. In addition, it should be noted that for 
IgM(GRA), methylation results, in particular the 
finding of (3,6)-Mez-Man and (3,4)-Mez-Man (see 
table 2), suggested tri- and/or tetraantennary 
oligosaccharides to occur also in fraction MS, 
besides the major, intersected biantennary glycan. 
This is consistent with the fact that this fraction 
does not react with Con A, and may account for the 
heterogeneity observed by TLC. Such tri- and/or 
tetraantennary structures were not detected by 
NMR spectroscopy, probably due to the low con- 
tent (10%) of that type of glycan. The percentage 
can be derived from the ratio of (3,4)-Mez-Man to 
(2)-Mel-Man, being 0.1: 0.9. 
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4. CONCLUSIONS 
The primary structures proposed for the major 
N-acetyllactosamine-type glycans from pathologi- 
cal IgM(ZAJ) and IgM(GRA) are given in fig.3. 
They differ with respect o the intersecting GlcNAc 
residue. The biantennary type of structure has 
already been described for human IgM [6,7], and 
for numerous other glycoproteins [24]. The inter- 
sected structure has so far been found only in a 
limited number of glycoproteins e.g., in glyco- 
phorin A [25], but mainly in immunoglobulins like 
human serum IgG [26,27], IgA [28], IgD [29,30] 
and sIgA [23], and not in human IgM or in mouse 
plasmocytoma IgM. 
With respect to the ‘H-NMR features of the 
compounds, it can be concluded that modification 
of GlcNAc-1 does not affect the chemical shifts of 
reporter group signals of residues which are more 
remote from GlcNAc-1 than the adjacent residues 
GlcNAc-2 and Fuc. This is in accordance with 
earlier observations [18,19]. The library of refer- 
ence data compiled for glycopeptides and reducing 
oligosaccharides ending in GlcNAc-2 [16] retains 
its validity, also for reduced oligosaccharides ending 
in GlcNAc-l-01. It should be emphasized that well- 
defined oligosaccharide-alditols prepared by re- 
duction of GlcNAc-1 after having accomplished 
the release of the oligosaccharide by hydrazino- 
lysis, have to be preferred for structural analysis 
far above the weakly defined products upon omit- 
ting the reduction step 122,311. 
The intersecting GlcNAc residue is known to 
exert a pronounced influence on the conformation 
and, by consequence, on the biosynthesis of a bi- 
antennary oligosaccharide chain [ 16,321. It remains 
a challenge to find out whether the presence of this 
intersecting GlcNAc in the carbohydrate chains of 
pathological IgM is somehow correlated with the 
clinical features of the patient. 
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